Safe closure versus no closure after stomach cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial compares two surgical approaches after radical gastrectomy—whether to close a small defect in the mesentery (the tissue that holds the intestines) or leave it alone. It aims to see which method is safer and helps patients recover better in stomach/near-esophagus (esophagogastric junction) cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your biopsy showed stomach or esophagogastric junction adenocarcinoma.
- Your tumor is in the lower part, middle, or upper part of the stomach, or at the junction near the esophagus, and you’re planned for curative surgery (R0) with lymph node removal (D1+/D2).
- Your BMI is under 30.
- You haven’t had major upper-abdominal surgery before (except laparoscopic gallbladder removal).
- You have not had chemo, radiation, targeted therapy, or immunotherapy yet.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways surgeons remove the entire stomach (total gastrectomy): laparoscopic (small keyhole cuts) versus open surgery (one larger cut). It’s testing which approach is safer and works better for people with certain stages of stomach cancer.
This study compares two ways surgeons reconnect the digestive tract after removing the whole stomach for certain stomach cancers near the esophagus. It aims to see which technique is safer and leads to better recovery and outcomes.
This trial compares two ways of removing lymph nodes during surgery: keyhole (laparoscopic) versus open surgery. It is for people with esophagus-stomach junction adenocarcinoma, aiming to see which approach works better and is safer.
This trial compares two laparoscopic surgeries for early-stage stomach cancer in the upper part of the stomach. It looks at whether preserving a nerve (celiac branch of vagus nerve) during surgery leads to better recovery while still removing the cancer safely.
This trial studies whether a minimally invasive (laparoscopic) removal of the entire stomach, along with lymph node removal, can be done safely and effectively for certain stomach cancers. It may be an option if your cancer is in the stomach, has limited spread to nearby lymph nodes, and can be fully removed.
This trial compares two types of surgery for stomach cancer that has grown into deeper layers but has not spread to distant organs. The goal is to see if a keyhole (laparoscopic) approach is as safe and effective as traditional open surgery.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.